CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 50K 100K 150K Q3 '21: 37.5K Q4 '21: 87.8K Q1 '22: 102.8K Q2 '22: 92.8K Q3 '22: 137.8K Q4 '22: 88.6K Q1 '23: 73.6K Q2 '23: 73.6K Q3 '23: 24.6K Q4 '23: 9K Q1 '24: 9K Q2 '24: 17K Q3 '24: 11K Q4 '24: 11K Q1 '25: 14K Q2 '25: 6K Q3 '25: 6K Q4 '25: 6K Q1 '26: 3K Q2 '26: 3K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 30K 60K 90K Q3 '21: 21K Q4 '21: 39.8K Q1 '22: 48K Q2 '22: 42.5K Q3 '22: 75.5K Q4 '22: 60.1K Q1 '23: 51.9K Q2 '23: 51.9K Q3 '23: 16.5K Q4 '23: 5.4K Q1 '24: 5.4K Q2 '24: 10.2K Q3 '24: 6.6K Q4 '24: 6.6K Q1 '25: 8.4K Q2 '25: 3.6K Q3 '25: 3.6K Q4 '25: 3.8K Q1 '26: 2K Q2 '26: 2K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '21: -2M Q4 '21: -3.1M Q1 '22: -4M Q2 '22: -5.3M Q3 '22: -5.4M Q4 '22: -10.2M Q1 '23: -10.2M Q2 '23: -9.6M Q3 '23: -10.1M Q4 '23: -5.6M Q1 '24: -5.6M Q2 '24: -6.1M Q3 '24: -5.6M Q4 '24: -5.7M Q1 '25: -6.3M Q2 '25: -5.9M Q3 '25: -6.1M Q4 '25: -6.1M Q1 '26: -5.9M Q2 '26: -6.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-21M -14M -7M 0 7M 14M 21M Q3 '21: -15.5M Q4 '21: 19.2M Q1 '22: -9.8M Q2 '22: -8.7M Q3 '22: -7.8M Q4 '22: -10.1M Q1 '23: -10M Q2 '23: -9.4M Q3 '23: -9.8M Q4 '23: -5.3M Q1 '24: -5.3M Q2 '24: -5.7M Q3 '24: -5.3M Q4 '24: -5.5M Q1 '25: -6.1M Q2 '25: -5.8M Q3 '25: -6M Q4 '25: -6M Q1 '26: -5.8M Q2 '26: -6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 25K 50K 75K Q3 '21: 16.5K Q4 '21: 47.9K Q1 '22: 54.7K Q2 '22: 50.2K Q3 '22: 62.2K Q4 '22: 28.5K Q1 '23: 21.7K Q2 '23: 21.7K Q3 '23: 8.1K Q4 '23: 3.6K Q1 '24: 3.6K Q2 '24: 6.8K Q3 '24: 4.4K Q4 '24: 4.4K Q1 '25: 5.6K Q2 '25: 2.4K Q3 '25: 2.4K Q4 '25: 2.2K Q1 '26: 994 Q2 '26: 994 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '21: -997.5K Q4 '21: -2.2M Q1 '22: -3.4M Q2 '22: -4.9M Q3 '22: -5.4M Q4 '22: -7.8M Q1 '23: -10.1M Q2 '23: -9.3M Q3 '23: -9.7M Q4 '23: -8M Q1 '24: -5.1M Q2 '24: -5.6M Q3 '24: -5.2M Q4 '24: -5.3M Q1 '25: -6M Q2 '25: -5.7M Q3 '25: -5.9M Q4 '25: -5.9M Q1 '26: -5.6M Q2 '26: -5.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 600M 1.2B 1.8B Q1 '19: 6.4M Q2 '19: 7.1M Q3 '19: 1.5B Q1 '20: 776.6M Q2 '20: 169.2M Q3 '20: 2.5M Q1 '21: 1.2B Q2 '21: 2.3M Q3 '21: 2.5M Q1 '22: 6.5M Q2 '22: 9M Q3 '22: 14.1M Q1 '24: 1.4M Q2 '24: 1.4M Q3 '24: 1.4M Q1 '25: 2M Q2 '25: 2.6M Q3 '25: 2.6M Q1 '26: 3.7M Q2 '26: 3.7M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-75.00 -50.00 -25.00 0.00 25.00 50.00 75.00 Q4 '18: -3.52 Q1 '19: -3.60 Q2 '19: -3.60 Q3 '19: -3.60 Q4 '19: -0.95 Q1 '20: -0.83 Q2 '20: -0.83 Q3 '20: -0.69 Q4 '20: -63.63 Q1 '22: -5.75 Q2 '22: -4.70 Q3 '22: -4.02 Q4 '22: -0.98 Q4 '24: -2.25 Q1 '25: -3.81 Q2 '25: -3.18 Q3 '25: -2.91 Q4 '25: -2.59 Q1 '26: -2.14 Q2 '26: -2.07 Q1 '19 Q4 '19 Q3 '20 Q2 '22 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.